Seroquel | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Seroquel
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2025-08-25

Seroquel

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

139 API Suppliers, 58 USDMF, 44 CEP/COS, 10 JDMF, 34 EU WC, 34 KDMF, 32 NDC API, 77 Listed Suppliers, $ API Reference Price

139 API Suppliers
58 USDMF
44 CEP/COS
10 JDMF
34 EU WC
34 KDMF
32 NDC API
77 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

75 Drugs in Development

75 Drugs in Development

INTERMEDIATES

37 Intermediate Suppliers

37 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1364 FDF Dossiers, 203 FDA Orange Book, 700 Europe, 137 Canada, 69 Australia, 109 South Africa, 146 Listed Dossiers

1364 FDF Dossiers
203 FDA Orange Book
700 Europe
137 Canada
69 Australia
109 South Africa
146 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG BASE, TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 200MG BASE, TABLET;ORAL - EQ 25MG BASE, TABLET;ORAL - EQ 300MG BASE, TABLET;ORAL - EQ 400MG BASE, TABLET;ORAL - EQ 50MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 150MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 300MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 400MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 50MG BASE

TABLET;ORAL - EQ 100MG BASE
TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 200MG BASE
TABLET;ORAL - EQ 25MG BASE
TABLET;ORAL - EQ 300MG BASE
TABLET;ORAL - EQ 400MG BASE
TABLET;ORAL - EQ 50MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 150MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 300MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 400MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 50MG BASE

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 6 DKSH, 11 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 3 Kirsch Pharma, 1 ACG Worldwide, 9 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 1 Avesta Pharma, 26 BASF, 2 Clariant, 11 Corel Pharma Chem, 7 DFE Pharma, 1 Esteem Industries, 2 Finar, 13 Gangwal Chemicals, 5 Ideal Cures, 4 Ingredion Pharma Solutions, 26 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

62 Fillers, Diluents & Binders, 48 Coating Systems & Additives, 40 Disintegrants & Superdisintegrants, 35 Direct Compression, 32 Granulation, 30 Solubilizers, 29 Controlled & Modified Release, 28 Thickeners and Stabilizers, 19 Parenteral, 18 Topical, 17 Film Formers & Plasticizers, 15 Lubricants & Glidants, 14 Co-Processed Excipients, 11 Chewable & Orodispersible Aids, 10 Emulsifying Agents, 9 Taste Masking, 7 API Stability Enhancers, 7 Rheology Modifiers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules

62 Fillers, Diluents & Binders
48 Coating Systems & Additives
40 Disintegrants & Superdisintegrants
35 Direct Compression
32 Granulation
30 Solubilizers
29 Controlled & Modified Release
28 Thickeners and Stabilizers
19 Parenteral
18 Topical
17 Film Formers & Plasticizers
15 Lubricants & Glidants
14 Co-Processed Excipients
11 Chewable & Orodispersible Aids
10 Emulsifying Agents
9 Taste Masking
7 API Stability Enhancers
7 Rheology Modifiers
5 Empty Capsules
5 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 60 News #PharmaBuzz

1 Data Compilation #PharmaFlow
60 News #PharmaBuzz

GLOBAL SALES INFORMATION

31 US Medicaid Prescriptions, 541 Regulatory FDF Prices, 13 Annual Reports

31 US Medicaid Prescriptions
541 Regulatory FDF Prices
13 Annual Reports

MARKET PLACE

13 APIs, 10 FDF Dossiers

13 APIs
10 FDF Dossiers

PATENTS & EXCLUSIVITIES

5 Health Canada Patents

5 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 4 USP, 5 JP, 41 Others

2 EDQM
4 USP
5 JP
41 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 112 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

5 All

01 5AstraZeneca Canada Inc.

filter Patent Reset all filters

5 All

01 52251944

filter Product Reset all filters

5 All

01 5Quetiapine Fumarate

filter Dosage Reset all filters

5 All

01 5Extended Release Tablet

filter Exp Date Reset all filters

5 All

01 52017-05-27

Product Main Page

01

AstraZeneca Canada Inc.

Quetiapine Hemifumarate

Pharmaconex

Not Confirmed

AstraZeneca Canada Inc.

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-05-27

Date Granted : 2007-04-10

Quetiapine Hemifumarate

Brand Name : SEROQUEL XR

Patent Number : 2251944

Filing Date : 1997-05-27

Strength per Unit : 50mg

Dosage Form : Extended Release Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-05-27

Date Granted : 2007-04-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

AstraZeneca Canada Inc.

Quetiapine Hemifumarate

Pharmaconex

Not Confirmed

AstraZeneca Canada Inc.

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-05-27

Date Granted : 2007-04-10

Quetiapine Hemifumarate

Brand Name : SEROQUEL XR

Patent Number : 2251944

Filing Date : 1997-05-27

Strength per Unit : 200mg

Dosage Form : Extended Release Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-05-27

Date Granted : 2007-04-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

AstraZeneca Canada Inc.

Quetiapine Hemifumarate

Pharmaconex

Not Confirmed

AstraZeneca Canada Inc.

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-05-27

Date Granted : 2007-04-10

Quetiapine Hemifumarate

Brand Name : SEROQUEL XR

Patent Number : 2251944

Filing Date : 1997-05-27

Strength per Unit : 300mg

Dosage Form : Extended Release Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-05-27

Date Granted : 2007-04-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

AstraZeneca Canada Inc.

Quetiapine Hemifumarate

Pharmaconex

Not Confirmed

AstraZeneca Canada Inc.

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-05-27

Date Granted : 2007-04-10

Quetiapine Hemifumarate

Brand Name : SEROQUEL XR

Patent Number : 2251944

Filing Date : 1997-05-27

Strength per Unit : 400mg

Dosage Form : Extended Release Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-05-27

Date Granted : 2007-04-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

AstraZeneca Canada Inc.

Quetiapine Hemifumarate

Pharmaconex

Not Confirmed

AstraZeneca Canada Inc.

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-05-27

Date Granted : 2007-04-10

Quetiapine Hemifumarate

Brand Name : SEROQUEL XR

Patent Number : 2251944

Filing Date : 1997-05-27

Strength per Unit : 150 mg

Dosage Form : Extended Release Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-05-27

Date Granted : 2007-04-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!